Cost-benefit of expanding cervical cancer screening

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 5, 2010, Pages 470-475

  Deng, Jing ^a   Tan, Hongzhuan ^a   Yang, Tubao ^a   Huang, Xin ^a   Zhou, Shujin ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Maternal and Child Health Care Hospital   (China)

Author keywords

Cervical cancer; Cost benefit analysis; Coverage of screening; Screening

Indexed keywords

ADULT; ARTICLE; CHINA; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; MASS SCREENING; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; CHINA; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77953768368     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.05.011     Document Type: Article

References (23)

1. American Cancer Society Cervical Cancer Screening. What are the key statistics for cervical cancer? [ EB/0L] . (2009-09-14) [2009-09-18] http://www.cancer.org/docroot/CRI/content/ CRI-2-4-1 X-What-are-the- key- statistics-for-cervical-cancer-8 . asp? rnav = cri.
2. Nuovo J, Melinkow J, Howell L P. New tests for cervical cancer screening [J]. Am Fam Physician, 2001, 64 (5): 780-786. (Pubitemid 32880124)
3. JIANG Shuqing, WANG Tao, TU Song'ai, et al. Investigation of cervical cancer in Cele county of Xinjiang, China [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2006, 22 (5): 379-381.
4. GENG Guanyi. Epidemiology [M]. 2 nd ed. Beijing : People' s Medical Publishing House, 1997: 154-156.
5. Brown M L, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life [ J ] . Annu Rev Public Health, 2001, 22: 91-113. (Pubitemid 32452500)
6. Berg A O, Atkins D. Screening for cervical cancer. Recommendations and rationale. Guide to clinical preventive services [M]. 2 nd ed. Washington DC: Office of Disease Prevention and Health Promotion, 2004.
7. LIAN Lijuan. LIN Qiaozhi. Gynecologic oncology [M]. 3 rd ed. Beijing : People' s Medical Publishing House, 2000: 253-265.
8. DAI Yi, CHEN Fengxiang, SHEN Qing, et al. An analysis of cancer mortality and life lost from 2002 to 2005 in Xihu District, Hangzhou [J]. Bulletin of Chinese Cancer, 2007, 16(12): 994-997.
9. REN Shengda, MI Zhenguo, MA Junfei, et al. Study on cervical cancer screening methods in low resource areas [J]. Cancer Research and Clinic, 2005, 17(6): 391-393.
10. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries : low average levels and large inequalities [J] . PLoS Med, 2008, 5 (6): e132.
11. Ronco G, Segnan N, Ponti A. Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes [J]. Int J Epidemiol, 1991, 20(2): 349-353.
12. Arrossi S, Ramos S, Paolino M, et al. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina [ J ] . Reprod Health Mat, 2008, 16(32): 50-58.
13. Cabeza E, Esteva M, Pujol A. Social disparities in breast and cervical cancer preventive practices [J]. Eur J Cancer Prev, 2007, 16 (4): 372-379.
14. Gao W, Desouza R, Paterson J, et al. Factors affecting uptake of cervical cancer screening among Chinese women in New Zealand [J]. Im J Gynecol Obstet, 2008, 103(1): 76-82.
15. Hislop T G, Deschamps M, Teh C, et al. Facilitators and barriers to cervical cancer screening among Chinese Canadian women [J]. Can J Public Health, 2003, 94 (1): 68-74. (Pubitemid 36157513)
16. Taylor V M, Jackson J C, Tu S P, et al. Cervical cancer screening among Chinese Americans [J]. Cancer Detect Prev, 2002, 26(2) : 139-145.
17. Abdullah A S, Leung T Y. Factors associated with the use of breastand cervical cancer screening services among Chinese women in HongKong [J]. Public Health, 2001, 115 (3): 212-217.
18. DONG Zhiwei. Guidelines for the early detection and therapy of cancer screening [M]. Beijing :Beijing University Medical Press, 2005.
19. PAN Song, HE Qincheng, ZHOU Baosen, et al. Study on health economics regarding the screening of gastric cancer in Zhuanghe high risk areas[J]. Chin J Epidemiol, 2005, 26 (10): 757-760.
20. Kim J J, Wright T C, Goldie S J. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance [J]. JAMA, 2002, 287(18): 2382-2390.
21. Goldie S J, Kim J J, Wright T C. Cost - effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 3 0 years or more [J]. Obstet Gynecol, 2004, 103 (4): 619-631.
22. Goldie S J, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost effectiveness of cervical cancer screening in five developing countries [J] . N Engl J Med, 2005, 353 (20): 2158-2168. (Pubitemid 41653107)
23. Sherlaw-Johnson C, Philips Z. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme [J]. Br J Cancer, 2004, 91(1): 84-91. (Pubitemid 39013049)